[go: up one dir, main page]

CN1450077A - Method for extracting polygonum cuspidatum tannic acid - Google Patents

Method for extracting polygonum cuspidatum tannic acid Download PDF

Info

Publication number
CN1450077A
CN1450077A CN 03116545 CN03116545A CN1450077A CN 1450077 A CN1450077 A CN 1450077A CN 03116545 CN03116545 CN 03116545 CN 03116545 A CN03116545 A CN 03116545A CN 1450077 A CN1450077 A CN 1450077A
Authority
CN
China
Prior art keywords
tannic acid
water
polygonum cuspidatum
ethyl acetate
giant knotweed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 03116545
Other languages
Chinese (zh)
Other versions
CN1313475C (en
Inventor
沈忠明
殷建伟
袁海波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Shanghai for Science and Technology
Original Assignee
University of Shanghai for Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Shanghai for Science and Technology filed Critical University of Shanghai for Science and Technology
Priority to CNB031165451A priority Critical patent/CN1313475C/en
Publication of CN1450077A publication Critical patent/CN1450077A/en
Application granted granted Critical
Publication of CN1313475C publication Critical patent/CN1313475C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an extraction method of Chinese medicinal material polygonum cuspidatum extract-polygonum cuspidatum tannin. The polygonum cuspidatum tannin as main component of polygoum cuspidatum extract has alpha-glycosidase inhibiting activity, can be used as main active component for preparing medicine for reducing blood sugar, also can be used as raw material for preparing medicine for curing diabetes and obesity. Its extraction method in cludes the following steps: pulverizing raw material, using water and methyl alcohol or water-containing alcohol to make extraction under the condition of heating, filtering, using petroleum ether to degrease the filtrate, using active carbon to decolour, the concentrating at normal pressure or reduced pressure, making the concentrated filtrate pass through ion exchange resin.

Description

虎杖提取物虎杖鞣酸的提取方法Extraction method of Polygonum cuspidatum extract Polygonum cuspidatum tannin

技术领域technical field

本发明涉及原药材虎杖提取物虎杖鞣酸的提取方法,属中草药化学提炼制备技术领域。The invention relates to a method for extracting Polygonum cuspidatum tannic acid from Polygonum cuspidatum extract, which belongs to the technical field of chemical extraction and preparation of Chinese herbal medicines.

背景技术Background technique

药用虎杖系蓼科蓼属植物,药用部分为根茎。主要化学成分很广很多,有:大黄素、大黄酚、葡萄糖甙、白藜芦醇甙、糖苷类、氨基酸、微量元素等,并富含缩合鞣质和多聚糖。The medicinal Polygonum cuspidatum is a plant of the genus Polygonaceae, and the medicinal part is the rhizome. The main chemical components are very wide and many, including: emodin, chrysophanol, glucoside, resveratrol glycoside, glycosides, amino acids, trace elements, etc., and are rich in condensed tannins and polysaccharides.

虎杖提取物中的鞣质或鞣酸,为糖尿病α-糖苷酶抑制活性,故可用作降血糖药物。The tannin or tannic acid in the extract of Polygonum cuspidatum has the inhibitory activity of diabetic α-glucosidase, so it can be used as a hypoglycemic drug.

发明内容Contents of the invention

本发明的目的是提供一种具有α-糖苷酶抑制活性的虎杖提取物,其有效部分即为具有良好降血糖活性的水溶性虎杖鞣酸。The object of the present invention is to provide a Polygonum cuspidatum extract with α-glucosidase inhibitory activity, the effective part of which is water-soluble Polygonum cuspidatum tannic acid with good hypoglycemic activity.

本发明的另一目的是提供一种虎杖提取物的制备工艺方法。Another object of the present invention is to provide a preparation process of Polygonum cuspidatum extract.

本发明的上述目的是通过以下技术方案来达到的。The above object of the present invention is achieved through the following technical solutions.

本发明的一种虎杖提取物虎杖鞣酸的提取方法,其特征在于,该方法包括以下几个工艺步骤:A method for extracting Polygonum cuspidatum extract Polygonum cuspidatum tannin of the present invention is characterized in that the method comprises the following process steps:

a.原药材虎杖经过粉碎后,用水、甲醇或含水醇在加热条件下提取,提取时a. The raw medicinal material Polygonum cuspidatum is crushed and extracted with water, methanol or water-containing alcohol under heating conditions.

  间2-30小时,溶剂用量为原药材的3-10倍;The time is 2-30 hours, and the amount of solvent is 3-10 times that of the original medicinal material;

b.过滤或离心分离,弃滤渣,取滤液或上层清液,将滤液或上层清液在温度b. filter or centrifuge, discard the filter residue, get the filtrate or supernatant, and put the filtrate or supernatant at temperature

  50-100℃保温5-30分钟,冰箱放置过夜;Keep warm at 50-100°C for 5-30 minutes, and place in the refrigerator overnight;

c.放入离心分离机,在2000-5000rmp离心分离5-20分钟,取上层清液;c. Put it into a centrifuge, centrifuge at 2000-5000rmp for 5-20 minutes, and take the supernatant;

d.将上层清液在分离漏斗中用石油醚脱脂2-5次;d. Degrease the supernatant with petroleum ether for 2-5 times in a separating funnel;

e.将脱脂后的提取液活性炭脱色,然后超滤去除低分子量杂质;e. decolorize the degreased extract with activated carbon, and then remove low molecular weight impurities by ultrafiltration;

f.将所得滤液上强酸性阳离子交换树脂,然后用蒸馏水洗脱,洗脱液调节其f. Strongly acidic cation exchange resin is applied to the resulting filtrate, and then eluted with distilled water, and the eluent adjusts its

  PH至中性后,在常压或减压下加热至60-100℃进行浓缩,然后用超滤膜After the pH reaches neutral, heat to 60-100°C under normal pressure or reduced pressure to concentrate, and then use an ultrafiltration membrane

  进行超滤,经干燥后即可得到褐色固体粉末,其主要成分为虎杖鞣酸。Carry out ultrafiltration, and after drying, a brown solid powder can be obtained, and its main component is Polygonum cuspidatum tannic acid.

本发明的另一种虎杖提取物虎杖鞣酸的提取方法,其特征在于,该方法包括以下几个工艺步骤:The extraction method of another kind of Polygonum cuspidatum extract Polygonum cuspidatum tannin of the present invention is characterized in that, the method comprises the following process steps:

a.将原药材虎杖先用水,乙醇或含水醇浸泡,浸软后用捣碎机粉碎,在加热条a. Soak the raw medicinal material Polygonum cuspidatum in water, ethanol or water-containing alcohol, macerate it after soaking, crush it with a masher, and put it in a heating bar

  件下,提取2-30小时,溶剂用量为原药材的3-10倍;Under certain conditions, extract for 2-30 hours, and the amount of solvent used is 3-10 times that of the original medicinal material;

b.过滤,弃滤渣,取滤液在常压或减压下加热至50-100℃,浓缩得浸膏;b. Filtrate, discard the filter residue, take the filtrate and heat it to 50-100°C under normal pressure or reduced pressure, and concentrate to obtain the extract;

c.加水溶解,用氯仿加热回流,弃氯仿层,所得水层用乙酸乙酯萃取2-3次,c. Add water to dissolve, heat to reflux with chloroform, discard the chloroform layer, and extract the resulting aqueous layer with ethyl acetate for 2-3 times,

  取乙酸乙酯层,再用NaOH水溶液萃取2-3次,取NaOH水溶液,用HCl调PHTake the ethyl acetate layer, and then extract it with NaOH aqueous solution for 2-3 times, take the NaOH aqueous solution, and adjust the pH with HCl

  值至2-6,加4-10%明胶水溶液,得沉淀物;When the value reaches 2-6, add 4-10% gelatin aqueous solution to obtain a precipitate;

d.沉淀用30-70%丙酮水溶液溶解,然后用离心机离心分离,弃沉淀,取丙酮溶d. The precipitate is dissolved with 30-70% acetone aqueous solution, then centrifuged with a centrifuge, the precipitate is discarded, and the acetone solution is taken.

  液,将其减压蒸馏浓缩,并回收丙酮,得到胶状固体物;Liquid, it is concentrated by distillation under reduced pressure, and reclaims acetone, obtains colloidal solid;

e.将所得胶状固体物用水溶解,再用乙酸乙酯萃取,将所得乙酸乙酯层减压浓e. Dissolve the obtained colloidal solid in water, then extract with ethyl acetate, and concentrate the obtained ethyl acetate layer under reduced pressure.

  缩,并回收乙酸乙酯,得到浓缩的胶状物;Shrink, and reclaim ethyl acetate, obtain concentrated jelly;

f.胶状物加适量水溶解,过滤,滤去沉淀不溶物,得到清液,将清液冷冻干燥f. The jelly is dissolved by adding appropriate amount of water, filtered, and the precipitated insoluble matter is filtered off to obtain a clear liquid, which is freeze-dried

  得橙黄色粉末,其主要成分为虎杖鞣酸。Obtain orange-yellow powder, the main component of which is Polygonum cuspidatum tannic acid.

本发明方法所制得的虎杖鞣酸,具有α-糖苷酶抑制活性,其作用机制是虎杖鞣酸通过与消化道内的许多酶作用,特别是对α-糖苷酶的抑制活性,从而调控了机体对葡萄糖等营养成分的吸收,使得它具有了抗营养性,对于肥胖的糖尿病患者而言,虎杖鞣酸不仅可以有效地降低血糖,而且可以减少其对营养成分的吸收,因此虎杖鞣酸可作为糖苷酶抑制剂类药物、也可作为减肥茶的主要成分。Polygonum cuspidatum tannic acid prepared by the method of the present invention has α-glucosidase inhibitory activity, and its action mechanism is that polygonum cuspidatum tannic acid interacts with many enzymes in the digestive tract, especially the inhibitory activity on α-glucosidase, thereby regulating the body The absorption of nutrients such as glucose makes it anti-nutritive. For obese diabetic patients, knotweed tannic acid can not only effectively lower blood sugar, but also reduce its absorption of nutrients. Therefore, knotweed tannic acid can be used as Glycosidase inhibitor drugs can also be used as the main component of slimming tea.

本发明方法的提取工艺,使用设备简单,分离提取容易操作,成本也较低。The extraction process of the method of the invention has the advantages of simple equipment, easy operation of separation and extraction, and low cost.

本发明制备物虎杖鞣酸作为抑制剂可降低血浆血糖浓度。Polygonum cuspidatum tannic acid, the preparation of the present invention, can reduce plasma blood sugar concentration as an inhibitor.

以下试验为虎杖鞣酸抑制剂对动物小鼠的降血糖作用。The following test is the hypoglycemic effect of Polygonum cuspidatum tannic acid inhibitor on animal mice.

试验1,虎杖鞣酸抑制剂一次给药对正常小鼠血糖含量的影响:小鼠45只,随机分为5组,分别灌胃生理盐水、拜糖苹(100mg/kg)、鞣酸抑制剂(50mg/kg、100mg/kg、150mg/kg)。禁食3h后断尾取血测定血浆血糖浓度。结果表明100,150mg/kg剂量均能明显降低正常小鼠血糖(见表1)。Experiment 1, the effect of one administration of Polygonum cuspidatum tannic acid inhibitor on the blood sugar content of normal mice: 45 mice were randomly divided into 5 groups, and they were fed with normal saline, Baitangping (100mg/kg) and tannic acid inhibitor respectively. (50mg/kg, 100mg/kg, 150mg/kg). After fasting for 3 hours, the blood was collected by docking the tail to measure the plasma glucose concentration. The results showed that both doses of 100 and 150 mg/kg could significantly reduce blood sugar in normal mice (see Table 1).

表1抑制剂一次给药对正常小鼠血糖含量的影响     组别     n  剂量(mg/kg)  血糖值(mmol/L)     生理盐水     10     -     7.80±0.48     拜糖苹     10     100     6.31±0.502 抑制剂     889     50100150     7.22±1.1115.50±0.4924.54±0.692 Table 1 Inhibitors once administered to the impact of blood sugar levels in normal mice group no Dose (mg/kg) Blood glucose level (mmol/L) normal saline 10 - 7.80±0.48 sugar apple 10 100 6.31±0.50 2 Inhibitor 889 50100150 7.22±1.11 1 5.50±0.49 2 4.54±0.69 2

与生理盐水组比较:1p<0.005,2p<0.001Compared with normal saline group: 1 p<0.005, 2 p<0.001

上述拜糖苹对照试剂为德国拜耳公司产品。The above-mentioned sugar apple contrast reagent is a product of German Bayer company.

试验2,虎杖鞣酸抑制剂连续多次给药对正常小鼠血糖含量的影响:小鼠30只,随机分为3组,分别灌胃生理盐水、拜糖苹(100mg/kg)、虎杖鞣酸抑制剂(100mg/kg),连续八天。末次给药后禁食3h,测定血糖浓度。可见,小鼠多次给药同样引起小鼠血糖的降低(见表2)。Test 2, the effect of continuous multiple administration of Polygonum cuspidatum tannic acid inhibitors on the blood sugar content of normal mice: 30 mice were randomly divided into 3 groups, which were administered with normal saline, Baitangping (100mg/kg), Polygonum cuspidatum tanned Acid inhibitor (100mg/kg) for eight consecutive days. After fasting for 3 hours after the last administration, the blood glucose concentration was measured. It can be seen that multiple administrations to mice also caused the reduction of blood sugar in mice (see Table 2).

表2抑制剂连续多次给药对正常小鼠血糖含量的影响   组别     n  血糖值(mmol/L)   生理盐水     10      6.30±0.89   拜糖苹     10      5.41±0.311   抑制剂     10      4.98±0.892 The influence of table 2 inhibitor continuous multiple administration on the blood sugar content of normal mice group no Blood glucose level (mmol/L) normal saline 10 6.30±0.89 sugar apple 10 5.41±0.31 1 Inhibitor 10 4.98±0.89 2

与生理盐水组比较:1p<0.005,2p<0.001Compared with normal saline group: 1 p<0.005, 2 p<0.001

上述拜糖苹对照试剂为德国拜耳公司产品。The above-mentioned sugar apple contrast reagent is a product of German Bayer company.

试验3,抑制剂对四氧嘧啶糖尿病小鼠血糖含量的影响:四氧嘧啶糖尿病小鼠30只,分为3组(组间血糖值差异不超过0.5mmol/L),分别灌胃生理盐水、拜糖苹(100mg/kg)、抑制剂(100mg/kg),连续八天。末次给药后禁食3h,取血测血糖。结果表明该抑制剂能够显著降低四氧嘧啶糖尿病小鼠的血糖(见表3)。表3抑制剂对四氧嘧啶糖尿病小鼠血糖含量的影响     组别     n 血糖值(mmol/L) 生理盐水     10     11.42±1.31 拜糖苹     10     8.32±1.231 抑制剂     10     6.85±0.981 Test 3, the influence of inhibitor on the blood sugar content of alloxan diabetic mice: 30 alloxan diabetic mice were divided into 3 groups (the difference in blood sugar value between the groups was not more than 0.5mmol/L), and they were fed with normal saline, Sugar apple (100mg/kg), inhibitor (100mg/kg), for eight consecutive days. After fasting for 3 hours after the last administration, blood was taken to measure blood sugar. The results showed that the inhibitor could significantly reduce the blood sugar of alloxan diabetic mice (see Table 3). The influence of table 3 inhibitor on the blood sugar content of alloxan diabetic mice group no Blood glucose level (mmol/L) normal saline 10 11.42±1.31 sugar apple 10 8.32±1.23 1 Inhibitor 10 6.85±0.98 1

与生理盐水组比较:1p<0.001Compared with normal saline group: 1 p<0.001

上述拜糖苹对照试剂为德国拜耳公司产品。The above-mentioned sugar apple contrast reagent is a product of German Bayer company.

具体实施方式Detailed ways

现将本发明虎杖鞣酸的提取方法的实施例叙述于后。Now the embodiment of the extraction method of Polygonum cuspidatum tannic acid of the present invention is described in the following.

实施例一:取300g中药虎杖加1200ml蒸馏水,浸软后用捣碎机粉碎,于60℃保温24小时,然后用离心分离机分离,离心分离机转速为5000rpm,离心时间10分钟,弃滤渣,取上层清液。将上层清液加热到80℃保温10分钟,然后冰箱放置过夜。再放入离心机,在5000rpm转速下离心分离10分钟,取上层清液。将上层清液在分液漏斗中用石油醚(30-60bp)脱脂3-4次。将脱脂后的提取液过活性炭柱脱色。然后超滤去除低分子量杂质,将所得滤液上732强酸性阳离子交换树脂,然后用蒸馏水洗脱。将洗脱液调PH到中性后,在常压或减压下加热至60-100℃进行浓缩,然后用超滤膜(截留分子量5000dalton)进行超滤浓缩,除去低分子杂质,经干燥后可得褐色固体粉末,其主要成分为虎杖鞣酸。Embodiment 1: get 300g Chinese medicine Rhizoma Polygonum cuspidatum and add 1200ml distilled water, macerate and pulverize with a masher, keep warm at 60°C for 24 hours, then separate with a centrifuge, the centrifuge speed is 5000rpm, centrifugation time 10 minutes, discard the filter residue, Take the supernatant. The supernatant was heated to 80° C. for 10 minutes, and then placed in the refrigerator overnight. Then put it into a centrifuge, centrifuge at 5000rpm for 10 minutes, and take the supernatant. The supernatant was defatted 3-4 times with petroleum ether (30-60bp) in a separatory funnel. The degreased extract was decolorized through an activated carbon column. Then ultrafiltration removes low-molecular-weight impurities, and the resulting filtrate is placed on 732 strong acidic cation exchange resin, and then eluted with distilled water. Adjust the pH of the eluate to neutral, then heat it to 60-100°C under normal pressure or reduced pressure for concentration, and then use an ultrafiltration membrane (molecular weight cut-off 5000dalton) for ultrafiltration concentration to remove low-molecular impurities. After drying Brown solid powder can be obtained, the main component of which is Polygonum cuspidatum tannic acid.

实施例二:将300g虎杖粗粉用1500ml95%乙醇冷浸24hr后,过滤,弃滤渣,取滤液,将滤液减压加热至80℃,浓缩得浸膏,浸膏加水溶解,用氯仿回流,弃氯仿层,所得水层用乙酸乙酯萃取2-3次,取乙酸乙酯层,再用NaOH萃取2-3次,取取NaOH水溶液,用HCl调PH值至4,加5%明胶水溶液,得沉淀物。沉淀物用50%丙酮水溶液溶解,然后用离心机离心分离,转速为5000rmp,分离10分钟,弃沉淀,取丙酮溶液,将其减压蒸馏浓缩,并回收丙酮,得到胶状固体物。将所得胶状固体物用水溶解,再用乙酸乙酯萃取,将所得乙酸乙酯层减压浓缩,并回收乙酸乙酯,得到浓缩的胶状物。所得胶状物加适量水溶解,过滤,滤去沉淀不溶物,得到清溶液,将清液冷冻干燥得橙黄色粉末,其主要成分为虎杖鞣酸。Example 2: 300g Polygonum cuspidatum coarse powder is cold-soaked with 1500ml95% ethanol for 24hr, filtered, the filter residue is discarded, the filtrate is taken, the filtrate is heated to 80°C under reduced pressure, concentrated to obtain an extract, the extract is dissolved in water, refluxed with chloroform, discarded Chloroform layer, the obtained water layer was extracted 2-3 times with ethyl acetate, the ethyl acetate layer was taken, and then extracted 2-3 times with NaOH, the NaOH aqueous solution was taken, the pH value was adjusted to 4 with HCl, and 5% gelatin aqueous solution was added, get sediment. The precipitate was dissolved with 50% acetone aqueous solution, then centrifuged with a centrifuge at 5000rmp for 10 minutes, discarded the precipitate, took the acetone solution, concentrated it by distillation under reduced pressure, and recovered the acetone to obtain a colloidal solid. The obtained jelly solid was dissolved in water, and then extracted with ethyl acetate, the obtained ethyl acetate layer was concentrated under reduced pressure, and the ethyl acetate was recovered to obtain a concentrated gum. Add appropriate amount of water to dissolve the obtained jelly, filter, and filter out the precipitated insoluble matter to obtain a clear solution, freeze-dry the clear solution to obtain an orange-yellow powder, the main component of which is Polygonum cuspidatum tannic acid.

Claims (3)

1. the extracting method of a Rhizoma Polygoni Cuspidati extract giant knotweed tannic acid is characterized in that, this method comprises following processing step:
A. the crude drug giant knotweed is through after pulverizing, and water, methyl alcohol or aqueous alcohol are extracted under heating condition, during extraction
Between 2-30 hour, solvent load be crude drug 3-10 doubly;
B. filter or centrifugation, abandon filter residue, get filtrate or supernatant liquid, with filtrate or supernatant liquid in temperature
50-100 ℃ is incubated 5-30 minute, and refrigerator is placed and spent the night;
C. put into separating centrifuge,, get supernatant liquid 2000-5000rmp centrifugation 5-20 minute;
D. supernatant liquid is used petroleum ether degreasing 2-5 time in separatory funnel;
E. with the extracting solution activated carbon decolorizing after the degreasing, low molecular weight impurities is removed in ultrafiltration then;
F. gained filtrate is gone up storng-acid cation exchange resin, use the distilled water wash-out then, elutriant is regulated it
PH is heated to 60-100 ℃ and concentrates to neutrality under normal pressure or decompression, use ultra-filtration membrane then
Carry out ultrafiltration, can obtain the brown solid powder after drying, its main component is the giant knotweed tannic acid.
2. the extracting method of a Rhizoma Polygoni Cuspidati extract giant knotweed tannic acid is characterized in that, this method comprises following processing step:
A. with crude drug giant knotweed elder generation water, ethanol or aqueous alcohol are soaked, and macerate the back and pulverize with stamp mill, in heating
Under the condition, extracted 2-30 hour, solvent load is 3-10 a times of crude drug;
B. filter, abandon filter residue, get filtrate and under normal pressure or decompression, be heated to 50-100 ℃, concentrate medicinal extract;
C. be dissolved in water, use the chloroform reflux, abandon chloroform layer, gained water layer ethyl acetate extraction 2-3
Inferior, get ethyl acetate layer, use NaOH aqueous solution extraction 2-3 time again, get the NaOH aqueous solution, use
HCl transfers pH value to 2-6, adds the 4-10% aqueous gelatin solution, gets throw out;
D. precipitation is used the whizzer centrifugation then with the dissolving of 30-70% aqueous acetone solution, abandons precipitation, gets third
Ketone solution concentrates its underpressure distillation, and reclaims acetone, obtains the colloidal solid thing;
E. with gained colloidal solid thing water dissolution, use ethyl acetate extraction again, the gained ethyl acetate layer is reduced pressure
Concentrate, and reclaim ethyl acetate, obtain spissated jelly;
F. jelly adds the suitable quantity of water dissolving, filters, and elimination precipitation insolubles obtains clear liquid, and clear liquid is freezing dried
Dry orange-yellow powder, its main component is the giant knotweed tannic acid.
3. the tannic acid product that extracting method extracted of a kind of Rhizoma Polygoni Cuspidati extract giant knotweed tannic acid according to claim 1 and 2 owing to have alpha-glucoside inhibiting activity, can be used for making the raw material of the medicine for the treatment of diabetes, obesity etc.
CNB031165451A 2003-04-22 2003-04-22 Method for extracting polygonum cuspidatum tannic acid Expired - Fee Related CN1313475C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031165451A CN1313475C (en) 2003-04-22 2003-04-22 Method for extracting polygonum cuspidatum tannic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031165451A CN1313475C (en) 2003-04-22 2003-04-22 Method for extracting polygonum cuspidatum tannic acid

Publications (2)

Publication Number Publication Date
CN1450077A true CN1450077A (en) 2003-10-22
CN1313475C CN1313475C (en) 2007-05-02

Family

ID=28684200

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031165451A Expired - Fee Related CN1313475C (en) 2003-04-22 2003-04-22 Method for extracting polygonum cuspidatum tannic acid

Country Status (1)

Country Link
CN (1) CN1313475C (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579603A (en) * 2007-11-14 2012-07-18 中国医学科学院药物研究所 Application of polygonum cuspidatum (PC) in prevention and treatment of insulin resistance and relative metabolic diseases
US20120183633A1 (en) * 2009-12-29 2012-07-19 Korea Institute Of Oriental Medicine Compositions and functional foods for treating and preventing obesity using polygonum cuspidatum butanol fraction and ethyl acetate fraction
CN104026159A (en) * 2014-07-08 2014-09-10 山东农业大学 Preparing method for botanical pesticides
CN104892695A (en) * 2014-03-05 2015-09-09 湖南省天金科技有限公司 Preparation method for extracting tannin with camellia oleifera shells
CN108348557A (en) * 2016-03-28 2018-07-31 心悦生医股份有限公司 Compositions containing tannins and uses thereof
TWI686192B (en) * 2017-02-13 2020-03-01 心悅生醫股份有限公司 Compositions containing tannic acids and uses thereof
US11154531B2 (en) 2020-02-08 2021-10-26 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
US11793823B2 (en) 2020-04-23 2023-10-24 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323582A (en) * 2001-05-29 2001-11-28 四川省中医药研究院中医研究所 Prepn. of injecta powder containing tannic acid component
CN1159326C (en) * 2002-09-03 2004-07-28 四川省中医药研究院中医研究所 Process of extracting tannic acid from Geranium wilfordii root and the use of the extractive

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579603A (en) * 2007-11-14 2012-07-18 中国医学科学院药物研究所 Application of polygonum cuspidatum (PC) in prevention and treatment of insulin resistance and relative metabolic diseases
US9504725B2 (en) * 2009-12-29 2016-11-29 Korea Institute Of Oriental Medicine Compositions and functional foods for treating and preventing obesity using polygonum cuspidatum butanol fraction and ethyl acetate fraction
CN102596211B (en) * 2009-12-29 2015-06-24 韩国韩医学研究院 Compositions and functional foods for treating and preventing obesity using polygonum cuspidatum butanol fraction and ethyl acetate fraction
US20120183633A1 (en) * 2009-12-29 2012-07-19 Korea Institute Of Oriental Medicine Compositions and functional foods for treating and preventing obesity using polygonum cuspidatum butanol fraction and ethyl acetate fraction
CN104892695A (en) * 2014-03-05 2015-09-09 湖南省天金科技有限公司 Preparation method for extracting tannin with camellia oleifera shells
CN104026159B (en) * 2014-07-08 2016-03-30 山东农业大学 A kind of preparation method of botanical insecticide
CN104026159A (en) * 2014-07-08 2014-09-10 山东农业大学 Preparing method for botanical pesticides
US11202791B2 (en) 2016-03-28 2021-12-21 Syneurx International (Taiwan) Corp. Compositions containing tannic acids and uses thereof
CN108348557A (en) * 2016-03-28 2018-07-31 心悦生医股份有限公司 Compositions containing tannins and uses thereof
TWI686192B (en) * 2017-02-13 2020-03-01 心悅生醫股份有限公司 Compositions containing tannic acids and uses thereof
US11154531B2 (en) 2020-02-08 2021-10-26 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
US11382924B2 (en) 2020-02-08 2022-07-12 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
US11779561B2 (en) 2020-02-08 2023-10-10 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
US11793823B2 (en) 2020-04-23 2023-10-24 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
US12521410B2 (en) 2020-04-23 2026-01-13 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof

Also Published As

Publication number Publication date
CN1313475C (en) 2007-05-02

Similar Documents

Publication Publication Date Title
CN100503626C (en) Application of membrane separation technology to produce raw materials containing phenylethanol glycosides from Cistanche deserticola and its preparation method
CN101016328B (en) A method for separating and purifying ursolic acid and oleanolic acid
CN101357952A (en) A kind of mussel polysaccharide MA with hypolipidemic activity and preparation method thereof
CN105777924A (en) Phellinus baumii fruit body anticancer activity polysaccharide PBPP and preparation method thereof
CN1450077A (en) Method for extracting polygonum cuspidatum tannic acid
EP1567177B1 (en) Mucuna pruriens and extracts thereof for the treatment of neurological diseases
CN101190276A (en) Separation and extraction method of sweet tea polyphenols
KR101348029B1 (en) The way of refining Panaxan which has efficacies of boosting hematopoiesis and immunity against cancer. And an analysis of defining its attributes and a composition for the efficacies
CN101224246A (en) A preparation method of loquat leaf total triterpene acid and its hypoglycemic function
CN106822331B (en) Application of litchi rind extract mainly containing latticed polymer polyphenol in preparing medicine for treating hyperuricemia
CN1401643A (en) Process for preparing total jujuboflavone with calmative and hypnosis action
CN1248992C (en) Preparation of oligomer and monomer from tannin by catalytic hydrogen degradation
CN117224625B (en) Application of Livistona chinensis seed extract in the preparation of drugs for the prevention and/or treatment of chronic colitis
CN100408054C (en) Method for extracting α-glucosidase inhibitor from Chinese medicine cinnamon
CN1312170C (en) Technique of preparing extract product of Radde Anemone Rhizome extract, and its application in preparing medication of treating cancer
CN115894728B (en) A kind of Milpa cactus polysaccharide MAP-2 and its preparation method and application
CN100539859C (en) Method for extracting tea polyphenols from tea leaves
CN1305866C (en) Method of extracting phenolic components from chinese medicine red sage root and its freeze dried powder injection agent
CN100546601C (en) Anti-tumor extract of salicymus root and its preparation method and application
CN101428077B (en) Traditional Chinese medicine composition for treating diabetes
CN114656515A (en) Preparation method of loquat leaf triterpenic acid extract
WO2022262241A1 (en) Forsythia suspensa leaf extract and use thereof for increasing abundance of akk in intestinal tracts
CN1803030A (en) Guava processing method
CN116284487B (en) A polysaccharide with protective effects against kidney damage
CN118255822B (en) New separation and identification of alanine disaccharide glycoside ADFG in red ginseng and new application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070502

Termination date: 20110422